GE HealthCare Technologies Inc.
GEHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19,672,000 | $19,552,000 | $18,341,000 | $17,585,000 |
| % Growth | 0.6% | 6.6% | 4.3% | – |
| Cost of Goods Sold | $11,467,000 | $11,630,000 | $11,162,000 | $10,411,000 |
| Gross Profit | $8,205,000 | $7,922,000 | $7,179,000 | $7,174,000 |
| % Margin | 41.7% | 40.5% | 39.1% | 40.8% |
| R&D Expenses | $1,311,000 | $1,205,000 | $1,026,000 | $816,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,269,000 | $4,282,000 | $3,631,000 | $3,563,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5,580,000 | $5,487,000 | $4,657,000 | $4,379,000 |
| Operating Income | $2,625,000 | $2,435,000 | $2,522,000 | $2,795,000 |
| % Margin | 13.3% | 12.5% | 13.8% | 15.9% |
| Other Income/Exp. Net | -$44,000 | -$74,000 | -$10,000 | $80,000 |
| Pre-Tax Income | $2,581,000 | $2,361,000 | $2,512,000 | $2,875,000 |
| Tax Expense | $531,000 | $743,000 | $563,000 | $600,000 |
| Net Income | $1,993,000 | $1,568,000 | $1,916,000 | $2,247,000 |
| % Margin | 10.1% | 8% | 10.4% | 12.8% |
| EPS | 4.37 | 3.04 | 4.22 | 4.9 |
| % Growth | 43.8% | -28% | -13.9% | – |
| EPS Diluted | 4.34 | 3.02 | 4.22 | 4.9 |
| Weighted Avg Shares Out | 456,000 | 455,000 | 453,926 | 454,710 |
| Weighted Avg Shares Out Dil | 459,000 | 458,000 | 453,926 | 454,710 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $26,000 | $0 | $34,000 |
| Interest Expense | $505,000 | $542,000 | $86,000 | $40,000 |
| Depreciation & Amortization | $580,000 | $610,000 | $633,000 | $625,000 |
| EBITDA | $3,666,000 | $3,513,000 | $3,165,000 | $3,540,000 |
| % Margin | 18.6% | 18% | 17.3% | 20.1% |